Trademark: 79296821
Status Date
Friday, December 2, 2022
Filing Date
Thursday, July 2, 2020
Published for Opposition
Tuesday, April 26, 2022
Abandoned Date
Friday, December 2, 2022
5 Biological preparations for medical purposes, namely, preparations for Dengue prognostication; diagnostic reagents for medical use; monoclonal antibody reagents for medical use; tagged antibodies for medical use, namely, preparations for Dengue prognostication; monoclonal antibodies for medical use, namely, reagents for medical diagnosis purposes; immunological antibodies for medical use, namely, immunoassay for medical diagnosis purposes; proteins for medical use in binding antibodies for diagnostic purposes; proteins for medical use in detecting antibodies, for diagnostic purposes; antigens, namely, a group of proteins that are related to severe Dengue; non-medicated serums for Dengue prognostication; immunoassay reagents for medical use, namely, medical diagnostic assays for testing of body fluids and blood; chemical products for immunoassay use, namely, medical monoclonal antibodies, for use in Dengue prognostication; reagents for medical use; test reagents for medical use; chemical test reagents namely, medical diagnostic reagents for testing of body fluids and blood for Dengue prognostication; laboratory reagents for medical use; test reagents for medical diagnosis; chemical reagents for use in medicine; diagnostic reagents for medicinal use; reagents for use in medical diagnosis
10 Diagnostic testing apparatus for use in immunoassay procedures for medical purposes; medical diagnostic apparatus for Dengue prognostication; diagnostic testing instruments for use in immunoassay procedure for medical purposes; tools for medical diagnostics, namely, the Dengue prognostic test kit; urological diagnostic devices, namely, the Dengue prognostic test kit; medical diagnostic instruments for the analysis of body fluids and blood for Dengue prognostication; medical diagnostic testing apparatus, namely, medical diagnostic apparatus for Dengue prognostication; apparatus for viewing diagnostic test strips, namely, for Dengue prognostic test kit; clinical chemistry analysers for medical use, namely, apparatus for blood fluids and blood analysis for Dengue prognostication; blood testing apparatus; blood testing equipment, namely, absorbance reader for Dengue prognostic test
The wording STRATIFIDEN has no meaning in a foreign language.
Dec 25, 2023
Final Decision Transaction Processed By Ib
Dec 4, 2023
Final Disposition Notice Sent To Ib
Dec 2, 2023
Final Disposition Notice Created, To Be Sent To Ib
Dec 2, 2022
Abandonment Notice E-Mailed - Inter Partes Decision
Dec 2, 2022
Abandonment - After Inter Partes Decision
Dec 2, 2022
Opposition Terminated No. 999999
Dec 2, 2022
Opposition Sustained No. 999999
Sep 20, 2022
Refusal Processed By Ib
Aug 30, 2022
Opposition Instituted No. 999999
Aug 25, 2022
Opposition Notice (Ib Refusal) Sent To Ib
Aug 25, 2022
Opposition Notice (Ib Refusal) Created
May 24, 2022
Extension Of Time To Oppose Received
Apr 26, 2022
Official Gazette Publication Confirmation E-Mailed
Apr 26, 2022
Published For Opposition
Apr 24, 2022
Notification Processed By Ib
Apr 17, 2022
Notification Of Possible Opposition - Processed By Ib
Apr 6, 2022
Notification Of Possible Opposition Sent To Ib
Apr 6, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 6, 2022
Notification Of Notice Of Publication E-Mailed
Mar 30, 2022
Notification Of Possible Opposition Sent To Ib
Mar 30, 2022
Notification Of Possible Opposition Created, To Be Sent To Ib
Mar 24, 2022
Approved For Pub - Principal Register
Sep 4, 2021
Notification Of Letter Of Suspension E-Mailed
Sep 4, 2021
Letter Of Suspension E-Mailed
Sep 4, 2021
Suspension Letter Written
Jul 21, 2021
Teas/Email Correspondence Entered
Jul 21, 2021
Correspondence Received In Law Office
Jul 21, 2021
Teas Response To Office Action Received
Feb 21, 2021
Refusal Processed By Ib
Jan 29, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Jan 28, 2021
Refusal Processed By Mpu
Jan 9, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Jan 8, 2021
Non-Final Action Written
Jan 5, 2021
Application Filing Receipt Mailed
Dec 30, 2020
Assigned To Examiner
Dec 30, 2020
New Application Office Supplied Data Entered
Dec 23, 2020
Limitation From Original Application Entered
Oct 29, 2020
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
